Actively Recruiting
The 5-FU Holter Study
Led by University of Auckland, New Zealand · Updated on 2024-12-09
10
Participants Needed
1
Research Sites
60 weeks
Total Duration
On this page
Sponsors
U
University of Auckland, New Zealand
Lead Sponsor
G
Gut Cancer Foundation
Collaborating Sponsor
AI-Summary
What this Trial Is About
To assess the feasibility of using ambulatory ECG monitoring (Holter monitor) for patients receiving 5-FU chemotherapy
CONDITIONS
Official Title
The 5-FU Holter Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with diagnosis of gastrointestinal malignancy
- Planned to receive either FOLFOX chemotherapy with any treatment intent
- Aged 6 18 years at time of signing informed consent form
You will not qualify if you...
- ECG showing left bundle branch block
- ECG showing left ventricular hypertrophy with strain
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Auckland City Hospital
Auckland, New Zealand, 1023
Actively Recruiting
Research Team
J
Jade Scott
CONTACT
S
Sarah Benge
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here